This is an open-label long-term follow-up study to evaluate the long-term safety and tolerability of sotatercept when added to background PAH therapy in adult participants with PAH. Patients can be considered for entry into the study if they are coming from a parent study using sotatercept (HYPERION).
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Jimmy Ford
Medicine-Pulmonary
Clinical or Medical
Interventional
Chronic Conditions
Heart and Circulation
Lungs and Breathing
Rare Diseases
22-2050
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
